Skip to content

VANSCHOONBEEK FARMA

Active
Private limited companyfounded 2017active for 9 yearsKerkhofweg 3, 3460 Bekkevoort, BelgiumKBO/BCE: BE 0678.754.530
Summary

VANSCHOONBEEK FARMA has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €250,700 and a net result of €222,740. Equity is growing by about 69% per year across the filed financial years. Its solvency ranks better than 27% of 12,404 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€1.5mtotal assets 2025
Equity
€250,700
Profit
€222,740
Turnover not published (abbreviated or micro format)
Financial health
84 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Holdings
1
Accounts 53 days early0 of 4 deeds read
Why 84raises riskSector: Retail trade (NACE 47)Liquidity: current ratio 0.47, cash €53,378, halvedlowers riskSize: total assets €1.5mFigures for financial year 2025 (filed 11-06-2026)Show the evidence

Checked score

Score 2025
84 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 39% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 42-32
equity 16.7% of total assets
Liquidity 35-29
short-term debt 41.6% · cash 3.6%
Profitability 87+2
return on assets 14.8%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,189 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.2%▲ +0.1 percentage points vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.2%▲ +0.1 percentage points vs 05-2026 07-2026: 0.3%▲ +0.1 percentage points vs 06-2026highest value 08-2026: 0.3%● unchanged vs 07-2026highest value 09-2026: 0.3%● unchanged vs 08-2026highest value 10-2026: 0.3%● unchanged vs 09-2026highest value
Credit of up to €21,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.47, compared with 3.18 in 2024, below 1; short-term debt: 41.6% and cash: 3.6% of total assets), and 83.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 33% on solvency, 32% on liquidity, 82% on profitability and 8% on growth.

The bankruptcy probability was computed on 13-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €1.5m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Figures for financial year 2025 (filed 11-06-2026)
NBB · annual accounts
raises risk · Liquidity: current ratio 0.47, cash €53,378, halved
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-06-2026, 53 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
53 days early
2024
9 days early
2023
22 days late
2022
30 days late
2021
6 days early
2020
11 days late
2019
8 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 July (4 of the last 5 filed years within 36 days of that day).
Companies Code · seven months
Where today falls in the filing period
13-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Financials · financial year 2025, abbreviated format

Equity
€250,700▼ 70.1%
2024 · €837,960
Total assets
€1.5m▼ 11.7%
2024 · €1.7m
Net result
€222,740▼ 0.5%
2024 · €223,942
Working capital
-€331,192
2024 · €329,043
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result falls in 2025; 2025 is 21% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.2m 2025 Net result€0.2m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€0.03m-€0.02m▼ 32.9%€0.06m▲ 196%€0.2m▲ 152%€0.3m▲ 99.0%€0.3m▼ 6.2%€0.3m▲ 1.5%€0.2m▼ 21.1%
Net result€0.02m-€0.02m▼ 27.9%€0.04mwithin the sector's middle half▲ 158%€0.1mwithin the sector's middle half▲ 156%€0.2mabove the sector's middle half▲ 106%€0.2mabove the sector's middle half▼ 6.6%€0.2mabove the sector's middle half▲ 1.8%€0.2mabove the sector's middle half▼ 0.5%
Equity€0.04m-€0.05m▲ 47.5%€0.1mwithin the sector's middle half▲ 83.2%€0.2mwithin the sector's middle half▲ 116%€0.4mabove the sector's middle half▲ 92.6%€0.6mwithin the sector's middle half▲ 50.1%€0.8mabove the sector's middle half▲ 36.5%€0.3mwithin the sector's middle half▼ 70.1%
Total assets€0.04m-€0.06m▲ 28.9%€1.2mwithin the sector's middle half▲ 2,008%€1.3mwithin the sector's middle half▲ 5.3%€1.4mabove the sector's middle half▲ 14.2%€1.5mwithin the sector's middle half▲ 4.6%€1.7mwithin the sector's middle half▲ 13.1%€1.5mabove the sector's middle half▼ 11.7%
Debt€0.008m-€0.003m▼ 60.1%€1.1m▲ 35,998%€1.0m▼ 4.6%€1.0m▼ 1.7%€0.9m▼ 13.5%€0.9m▼ 3.0%€1.3m▲ 45.0%
Working capital€0.03m-€0.05m▲ 49.9%-€0.07mbelow the sector's middle half-€0.03mbelow the sector's middle half▲ 59.7%€0.1mabove the sector's middle half€0.2mwithin the sector's middle half▲ 130%€0.3mwithin the sector's middle half▲ 43.8%-€0.3mbelow the sector's middle half
Solvency82.7%-94.6%▲ 11.9pp8.2%below the sector's middle half▼ 86.4pp16.9%below the sector's middle half▲ 8.7pp28.5%within the sector's middle half▲ 11.6pp40.8%within the sector's middle half▲ 12.4pp49.3%within the sector's middle half▲ 8.4pp16.7%within the sector's middle half▼ 32.6pp
Current ratio5.24-23.37▲ 18.130.27below the sector's middle half▼ 23.100.76below the sector's middle half▲ 0.491.59within the sector's middle half▲ 0.833.16above the sector's middle half▲ 1.573.18above the sector's middle half▲ 0.020.47below the sector's middle half▼ 2.71
Return on assets (ROA)54.5%-30.5%▼ 24.0pp3.7%within the sector's middle half▼ 26.8pp9.1%within the sector's middle half▲ 5.3pp16.4%above the sector's middle half▲ 7.3pp14.6%above the sector's middle half▼ 1.8pp13.2%above the sector's middle half▼ 1.5pp14.8%above the sector's middle half▲ 1.7pp
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them.
Why a figure moved sharply
  • 2022 Net result +106% on 2021. The accounts now follow the micro format, last year the abbreviated format.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.5m
Fixed assets €1.2m ▼ 1.0%
Current assets €293,572 ▼ 38.9%
Equity and liabilities €1.5m
Equity €250,700 ▼ 70.1%
Debt €1.3m ▲ 45.0%
Debt's share of the balance-sheet total rises from 50.7% to 83.3%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€254,611▼
2024 · €312,390
Cash flow
€234,796▲
2024 · €228,828
Debt to equity
4.99▲
2024 · 1.03
ROE
88.8%▲
2024 · 26.7%
Interest coverage
19.74▼
2024 · 20.80
Debt ≤ 1 year
€624,764▲
2024 · €151,197
Debt > 1 year
€623,493▼
2024 · €699,859
Income taxes
€52,915▼
2024 · €68,546
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.7m€1.5m▼
Fixed assets21/28€1.2m€1.2m▼
Tangible fixed assets22/27€0.06m€0.04m▼
Plant, machinery and equipment23€0.002m€0.002m▼
Furniture and vehicles24€0.05m€0.04m▼
Financial fixed assets28€1.2m€1.2m=
Current assets29/58€0.5m€0.3m▼
Amounts receivable within one year40/41€0.3m€0.2m▼
Trade receivables40€0.2m€0.1m▼
Other amounts receivable41€0.04m€0.1m▲
Cash at bank and in hand54/58€0.2m€0.05m▼
Deferred charges and accrued income490/1€0.001m€0.001m▼
Equity and liabilities
Total equity and liabilities10/49€1.7m€1.5m▼
Equity10/15€0.8m€0.3m▼
Contributions10/11€0.02m€0.02m=
Reserves13€0.8m€0.2m▼
Tax-exempt reserves132€132€132=
Distributable reserves133€0.8m€0.2m▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€0.9m€1.3m▲
Amounts payable after more than one year17€0.7m€0.6m▼
Financial debts170/4€0.7m€0.6m▼
Amounts payable within one year42/48€0.2m€0.6m▲
Current portion of amounts payable after more than one year42€0.08m€0.08m▲
Financial debts43€0.03m€0.02m▼
Credit institutions430/8€0.03m€0.02m▼
Trade debts44€0€0.006m▲
Suppliers440/4€0€0.006m▲
Taxes, remuneration and social security45€0.05m€0.03m▼
Taxes450/3€0.05m€0.03m▼
Other amounts payable47/48€0.002m€0.5m▲
Accrued charges and deferred income492/3€0.01m€0.003m▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.005m€0.01m▲
Other operating charges640/8€0.001m€0.001m▼
Gross operating margin9900€0.3m€0.3m▼
Operating profit (loss)9901€0.3m€0.2m▼
Financial income75/76B-€0.05m
Recurring financial income75-€0.05m
Financial charges65/66B€0.02m€0.01m▼
Recurring financial charges65€0.02m€0.01m▼
Profit (loss) for the period before taxes9903€0.3m€0.3m▼
Income taxes67/77€0.07m€0.05m▼
Profit (loss) for the period9904€0.2m€0.2m▼
Profit (loss) for the period to be appropriated9905€0.2m€0.2m▼
Appropriation of the result
Profit (loss) to be appropriated9906€0.2m€0.2m▼
Transfer from equity791/2€0€0.8m▲
Transfer to equity691/2€0.2m€0.2m▼
To other reserves6921€0.2m€0.2m▼
Profit to be distributed694/7€0€0.8m▲
Return on contributions (dividend)694€0€0.8m▲

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€722€1,118€1,118€1,350€1,650€1,764€4,886€12,055▲ 147%
Other operating charges640/8---€348€868€960€1,162€1,141▼ 1.8%
Gross operating margin9900€33,782€23,701€65,858€163,873€325,234€305,566€313,553€255,752▼ 18.4%
Operating profit (loss)9901€32,365€21,726€64,342€162,175€322,716€302,841€307,505€242,556▼ 21.1%
Financial income75/76B-------€46,000-
Recurring financial income75--€0----€46,000-
Financial charges65/66B---€16,083€15,306€16,195€15,017€12,900▼ 14.1%
Recurring financial charges65€45€36€8,477€16,083€15,306€16,195€15,017€12,900▼ 14.1%
Profit (loss) for the period before taxes9903€32,320€21,690€55,865€146,092€307,410€286,646€292,488€275,655▼ 5.8%
Income taxes67/77€8,367€4,410€11,234€31,995€71,946€66,651€68,546€52,915▼ 22.8%
Profit (loss) for the period9904€23,953€17,279€44,631€114,097€235,463€219,995€223,942€222,740▼ 0.5%
Profit (loss) for the period to be appropriated9905€23,953€17,147€44,631€114,097€235,463€219,995€223,942€222,740▼ 0.5%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€0.04m€0.06m€1.2m€1.3m€1.4m€1.5m€1.7m€1.5m▼ 11.7%
Fixed assets21/28€0.004m€0.006m€1.2m€1.2m€1.2m€1.2m€1.2m€1.2m▼ 1.0%
Tangible fixed assets22/27€0.004m€0.006m€0.005m€0.005m€0.004m€0.004m€0.06m€0.04m▼ 21.5%
Plant, machinery and equipment23-----€0.002m€0.002m€0.002m▼ 11.7%
Furniture and vehicles24---€0.005m€0.004m€0.002m€0.05m€0.04m▼ 21.9%
Financial fixed assets28--€1.2m€1.2m€1.2m€1.2m€1.2m€1.2m=
Current assets29/58€0.04m€0.05m€0.03m€0.09m€0.3m€0.3m€0.5m€0.3m▼ 38.9%
Amounts receivable within one year40/41€0.007m€0.008m€0.001m€0.001m€0.002m€0.04m€0.3m€0.2m▼ 15.8%
Trade receivables40---€130--€0.2m€0.1m▼ 54.5%
Other amounts receivable41---€0.001m€0.002m€0.04m€0.04m€0.1m▲ 222%
Cash at bank and in hand54/58€0.03m€0.04m€0.02m€0.09m€0.3m€0.3m€0.2m€0.05m▼ 72.6%
Deferred charges and accrued income490/1---€475€475€342€0.001m€0.001m▼ 0.3%
Equity and liabilities
Total equity and liabilities10/49€0.04m€0.06m€1.2m€1.3m€1.4m€1.5m€1.7m€1.5m▼ 11.7%
Equity10/15€0.04m€0.05m€0.1m€0.2m€0.4m€0.6m€0.8m€0.3m▼ 70.1%
Contributions10/11€0.01m€0.01m-€0.01m€0.02m€0.02m€0.02m€0.02m=
Reserves13€0.02m€0.04m€0.09m€0.2m€0.4m€0.6m€0.8m€0.2m▼ 71.7%
Non-distributable reserves130/1---€0.002m-----
Reserves not available under the articles1311---€0.002m-----
Tax-exempt reserves132---€132€132€132€132€132=
Distributable reserves133---€0.2m€0.4m€0.6m€0.8m€0.2m▼ 71.7%
Profit (loss) carried forward14-----€0€0€0-
Amounts payable17/49€0.008m€0.003m€1.1m€1.0m€1.0m€0.9m€0.9m€1.3m▲ 45.0%
Amounts payable after more than one year17--€1.0m€0.9m€0.8m€0.8m€0.7m€0.6m▼ 10.9%
Financial debts170/4---€0.9m€0.8m€0.8m€0.7m€0.6m▼ 10.9%
Amounts payable within one year42/48€0.008m€0.002m€0.09m€0.1m€0.2m€0.1m€0.2m€0.6m▲ 313%
Current portion of amounts payable after more than one year42---€0.07m€0.07m€0.07m€0.08m€0.08m▲ 1.5%
Financial debts43---€0.009m€0.04m€0.03m€0.03m€0.02m▼ 19.5%
Credit institutions430/8---€0.009m€0.04m€0.03m€0.03m€0.02m▼ 19.5%
Trade debts44€0.006m€0.001m-€0.002m€114€0.001m€0€0.006m-
Suppliers440/4---€0.002m€114€0.001m€0€0.006m-
Taxes, remuneration and social security45---€0.01m€0.003m€0.003m€0.05m€0.03m▼ 29.0%
Taxes450/3---€0.01m€0.003m€0.003m€0.05m€0.03m▼ 29.0%
Other amounts payable47/48---€0.02m€0.05m€0.003m€0.002m€0.5m▲ 22,539%
Accrued charges and deferred income492/3---€0.007m€0.009m€0.008m€0.01m€0.003m▼ 75.8%
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€0.02m€0.02m€0.04m€0.1m€0.2m€0.2m€0.2m€0.2m▼ 0.5%
+ Depreciation and write-downs630€0.001m€0.001m€0.001m€0.001m€0.002m€0.002m€0.005m€0.01m▲ 147%
Operating cash flow (approximation)€0.02m€0.02m€0.05m€0.1m€0.2m€0.2m€0.2m€0.2m▲ 2.6%
Investment in fixed assets (approximation)--€0.003m-€1.2m-€0.002m€0-€0.002m-€0.06m€0-
Change in cash-€0.01m-€0.02m€0.06m€0.2m€0.03m-€0.1m-€0.1m▼ 37.6%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (8)
Financial year Type Filed Reference
31-12-2025 abbreviated format 08-06-2026 2026-00153610
31-12-2024 abbreviated format 22-07-2025 2025-00294855
31-12-2023 abbreviated format 22-08-2024 2024-00365384
31-12-2022 micro format 30-08-2023 2023-00381076
31-12-2021 abbreviated format 25-07-2022 2022-20222410
31-12-2020 abbreviated format 11-08-2021 2021-47900487
31-12-2019 abbreviated format 23-07-2020 2020-34900459
31-12-2018 abbreviated format 26-07-2019 2019-39400452

Similar companies · same sector, comparable size

Of the 5,203 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,876. 3,536 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2023 to 2025 · 3 entries · €361 awarded · €361 paid
Year Entries AwardedPaid
2025 1 €104€104
2024 1 €92€92
2023 1 €165€165
Schemes
3 entries · €361 · €361 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 4 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

Group and network

Holdings and subsidiaries

1 holding

Holdings 1

According to the 2025 annual accounts of VANSCHOONBEEK FARMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Connections & network

No directors read yet: 0 of 4 Gazette acts processed.

History

VANSCHOONBEEK FARMA was incorporated on 20 July 2017.1 Total assets rose from €43,955 in 2018 to €1.5m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
08-06
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
22-07
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
22-08
NBB filing Annual accounts filed
financial year 2023 · abbreviated format · 22 days late
2023
31-12
Financial Equity above €500,000equity €614,018 ▲50.1%
A profit in every financial year since 2018 builds equity to €614,018.
30-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 30 days late
2022
31-12
Financial Highest result from 2018 to 2025net €235,463 ▲106%
Operating result €322,716, net result €235,463, both a record.
31-12
Financial Liquidity more than doubledcurrent ratio 1.59
Current ratio from 0.76 to 1.59.
25-07
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
2021
31-12
Financial Equity above €200,000equity €212,360 ▲116%
A profit in every financial year since 2018 builds equity to €212,360.
11-08
NBB filing Annual accounts filed
financial year 2020 · abbreviated format · 11 days late
2020
23-07
NBB filing Annual accounts filed
financial year 2019 · abbreviated format
2019
31-12
Financial Weakest financial yearnet €17,279 ▼27.9%
Net result drops to €17,279, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity more than quadruplescurrent ratio 23.37
Current ratio from 5.24 to 23.37; short-term debt falls from €7,602 to €2,162.
26-07
NBB filing Annual accounts filed
financial year 2018 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 4 deeds read
About the unread acts

We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded20-07-2017
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0678754530
Also 9925:BE0678754530
Registered 07-07-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 13 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Bekkevoortunit no. 2.266.219.017
1 permission
Apotheek (LM>3 maand) · since 30-08-2018

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Bekkevoort · 1 establishment unit since 2017
registered office establishment The establishment unit on the map
Ground area
843 m²
Building footprint
206 m²
Building volume
627 m³
Parcel 24008C0004/00K000, Flanders · tallest building 8.4 m. Linked by address, not a title deed.
1 establishment unit
VANSCHOONBEEK FARMA
Kerkhofweg 3, 3460 BekkevoortRetail sale of pharmaceutical products
since 2017unit no. 2.266.219.017
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
24008C0004/00K000 Flanders 843 m² 1 · 206 m² 8.4 m · 1
How the parcels are linked
Good to know
The parcel matches the address exactly.